NasdaqCM - Delayed Quote • USD
Sanara MedTech Inc. (SMTI)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.07 | -0.08 | -0.22 | 0.56 |
| Low Estimate | -0.07 | -0.08 | -0.22 | 0.56 |
| High Estimate | -0.07 | -0.08 | -0.22 | 0.56 |
| Year Ago EPS | -0.14 | -0.22 | -0.52 | -0.22 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 18.5M | 19.2M | 78M | 90.1M |
| Low Estimate | 18.5M | 19.2M | 78M | 90.1M |
| High Estimate | 18.5M | 19.2M | 78M | 90.1M |
| Year Ago Sales | 15.52M | 16.9M | 64.99M | 78M |
| Sales Growth (year/est) | 19.20% | 13.60% | 20.00% | 15.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.33 | -0.13 | 0 | -0.13 |
| EPS Actual | -0.14 | -0.22 | -0.13 | -0.03 |
| Difference | 0.19 | -0.09 | -0.13 | 0.1 |
| Surprise % | 57.60% | -69.20% | -- | 76.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.08 | -0.22 | 0.56 |
| 7 Days Ago | -0.07 | -0.08 | -0.22 | 0.56 |
| 30 Days Ago | -0.07 | -0.08 | -0.22 | 0.56 |
| 60 Days Ago | 0 | 0 | 0.52 | 0 |
| 90 Days Ago | 0 | 0 | 0.52 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SMTI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 50.00% | -- | -- | 5.40% |
| Next Qtr. | 63.60% | -- | -- | 10.90% |
| Current Year | 57.70% | -- | -- | 4.50% |
| Next Year | 354.50% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 3/27/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 2/6/2024 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 11/15/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/26/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/22/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/17/2023 |
Related Tickers
ECIA Encision Inc.
0.4400
0.00%
POCI Precision Optics Corporation, Inc.
5.60
-1.06%
NXGL NEXGEL, Inc.
2.2100
-5.15%
PDEX Pro-Dex, Inc.
18.68
+1.19%
ANIK Anika Therapeutics, Inc.
25.57
-0.04%
INFU InfuSystem Holdings, Inc.
8.12
+6.70%
BLFS BioLife Solutions, Inc.
17.53
+3.97%
UTMD Utah Medical Products, Inc.
65.92
-0.56%
LMAT LeMaitre Vascular, Inc.
65.46
+3.92%
DIM.PA Sartorius Stedim Biotech S.A.
208.30
+2.41%